TITLE

Treatment of active Crohn's disease in children using partial enteral nutrition with liquid formula: a randomised controlled trial

AUTHOR(S)
Johnson, T.; Macdonald, S.; Hill, S. M.; Thomas, A.; Murphy, M. S.
PUB. DATE
March 2006
SOURCE
Gut;Mar2006, Vol. 55 Issue 3, p356
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background and aims: Total enteral nutrition (TEN) with a liquid formula can suppress gut inflammation and induce remission in active Crohn's disease. The mechanism is obscure. Studies have suggested that long term nutritional supplementation with a liquid formula (partial enteral nutrition (PEN)) may also suppress inflammation and prevent relapse. The aim of this study was to compare PEN with conventional TEN in active Crohn's disease. Patients and methods: Fifty children with a paediatric Crohn's disease activity index (PCDAI) >20 were randomly assigned to receive 50% (PEN) or 100% (TEN) of their energy requirement as elemental formula for six weeks. The PEN group was encouraged to eat an unrestricted diet while those receiving TEN were not allowed to eat. The primary outcome was achievement of remission (PCDAI < 10). Secondary analyses of changes in erythrocyte sedimentation rate (ESR), C reactive protein, albumin, and platelets were performed to look for evidence of anti-inflammatory effects. Results: Remission rate with PEN was lower than with TEN (15% v 42%; p = 0.035). Although PCDAI fell in both groups (p = 0.001 for both), the reduction was greater with TEN (p = 0.005). Moreover, the fall in PCDAI with PEN was due to symptomatic and nutritional benefits. With both treatments there were significant improvements in relation to abdominal pain, ‘sense of wellbeing’, and nutritional status. However, only TEN led to a reduction in diarrhoea (p = 0.02), an increase in haemoglobin and albumin, and a fall in platelets and ESR. Conclusions: TEN suppresses inflammation in active Crohn's disease but PEN does not. This suggests that long term nutritional supplementation, although beneficial to some patients, is unlikely to suppress inflammation and so prevent disease relapse.
ACCESSION #
20098087

 

Related Articles

  • PRESENT; PREScription of Enteral Nutrition in pediaTric Crohn's disease in Spain. Navas-López, Victor Manuel; Martín-de-Carpi, Javier; Segarra, Oscar; García-Burriel, José Ignacio; Díaz-Martín, Juan José; Rodríguez, Alejandro; Medina, Enrique; Juste, Mercedes // Nutricion Hospitalaria;mar2014, Vol. 29 Issue 3, p537 

    Objectives: Exclusive enteral nutrition (EEN) is one of the therapeutic strategies used to induce remission in pediatric Crohn's disease (CD). Although its use is recommended in clinical practice guidelines and consensus documents, the frequency of this practice in Spain is unknown. Methods: A...

  • Special issues in pediatric inflammatory bowel disease. Dubinsky, Marla // World Journal of Gastroenterology;1/21/2008, Vol. 14 Issue 3, p413 

    The incidence of pediatric inflammatory bowel disease (IBD) is rising and recent advances in diagnostics and therapeutics have improved the care provided to these children. There are distinguishing features worth noting between early onset and adult onset IBD. Physical and psychosocial...

  • Implementation of a registry for quality improvement. Brennan, Caitlin W.; Groves, Patricia S.; Colletti, Richard B. // Implementation Science;2013, Vol. 8 Issue Suppl 1, Special section p1 

    The article discusses the ImproveCareNow network that was developed to enhance quality improvement (QI) research initiatives for the benefit of pediatric patients with inflammatory bowel disease (IBD) and Crohn's Disease. How the registry can be a vital part of QI and QI research was described...

  • ULCERATIVE COLITIS AND CROHN DISEASE IN CHILDREN -- AN EVOLVING PROBLEM IN ROMANIA. Becheanu, Cristina; Lesanu, Gabriela; Smadeanu, Roxana; Tincu, Iulia // Romanian Journal of Rheumatology;2014, Vol. 23 Issue 2, p135 

    Objectives. In the past few years we observed an increase in the number of patients with inflammatory bowel disease. We aimed to determine the epidemiology of this pathology among children in Romania over a 10 years period. Matherial and methods. The survey was conducted in Pediatric...

  • Growth in children receiving contemporary disease specific therapy for Crohn's disease. Malik, Salma; Mason, Avril; Bakhshi, Andisheh; Young, David; Bishop, Jonathan; Garrick, Victoria; McGrogan, Paraic; Russell, Richard K.; Ahmed, S. Faisal // Archives of Disease in Childhood;Aug2012, Vol. 97 Issue 8, p698 

    Introduction It is unclear whether recent therapeutic advances have improved the growth of children with Crohn's disease (CD). Aim To assess the frequency of short stature and poor growth and their relationship to disease course and therapy in children with CD. Methods The anthropometric and...

  • Paediatric Inflammatory Bowel Disease: A Mechanistic Approach to Investigate Exclusive Enteral Nutrition Treatment. Nahidi, Lily; Day, Andrew S.; Lemberg, Daniel A.; Leach, Steven T. // Scientifica;2014, p1 

    The inflammatory bowel diseases (IBD) include Crohn's disease (CD) and ulcerative colitis. The disease may present at any age although the peak of presentation is the second and third decades of life. The incidences of these diseases are increasing around the world with the age of presentation...

  • Kabuki Syndrome and Crohn Disease in a Child with Familial Hypocalciuric Hypercalcemia. Ho, Josephine; Fox, Danya; Innes, A. Micheil; McLeod, Ross; Butzner, Decker; Johnson, Nicole; Trevenen, Cynthia; Kendrick, Victoria; Cole, David E. C. // Journal of Pediatric Endocrinology & Metabolism;Sep2010, Vol. 23 Issue 9, p975 

    The article offers information on a study which described a pediatric case of familial hypocalciuric hypercalcemia (FHH) associated with Kabuki syndrome and Crohn disease. A review of the related literature on FHH and Kabuki syndrome is provided. Mutations of the calcium sensing receptor (CASR)...

  • Pediatric Inflammatory Bowel Disease. Antonioli, Donald A. // Pediatric & Developmental Pathology;Jan/Feb2005, Vol. 8 Issue 1, p2 

    Focuses on pediatric inflammatory bowel disease (IBD). Achievement of diagnosis by eliminating known causes of enteritis and colitis; Effects caused by the endoscopic procedure; Effects of colonic cleaning procedures; Histologic features of enteric colitis; Characteristics of pediatric IBD;...

  • Role of wireless capsule endoscopy in reclassifying inflammatory bowel disease in children. Ouahed, Jodie; Shagrani, Mohammad; Sant'Anna, Ana // Jornal de Pediatria;Mar/Apr2013, Vol. 89 Issue 2, p204 

    Objective: To evaluate the role of wireless capsule endoscopy in identifying small bowel lesions in pediatric patients with newly diagnosed colonic inflammatory bowel disease (IBD) type unclassified (IBDU), and to assess whether capsule endoscopy findings result in altered patient management....

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics